LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
SLRN Acelyrin
- 2.680
- +0.120+4.69%
Close Feb 28 16:00 ET
- 2.680
- 0.0000.00%
Post 18:47 ET
268.87MMarket Cap-1.01P/E (TTM)
2.710High2.560Low1.63MVolume2.570Open2.560Pre Close4.36MTurnover2.70%Turnover RatioLossP/E (Static)100.33MShares8.76052wk High0.51P/B161.39MFloat Cap1.84552wk Low--Dividend TTM60.22MShs Float29.880Historical High--Div YieldTTM5.86%Amplitude1.845Historical Low2.674Avg Price1Lot Size
Acelyrin News
Acelyrin | SCHEDULE 13D/A: Others
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | SCHEDULE 13D: Others
Acelyrin | SCHEDULE 13G/A: Others
Acelyrin | SCHEDULE 13G/A: Others
Acelyrin | SCHEDULE 13D/A: Others
Acelyrin | SCHEDULE 13G/A: Others
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Acelyrin | 8-K: Current report
Acelyrin | 8-K: Current report
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Mpofu Shephard
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Kim Mina
Trending Stocks
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l
Moomoo News Global
Feb 24 22:30
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites